SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
CT ORDER

CT ORDER

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
ARS

An annual report to security holders

Annual Filings
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML

Data provided by Kaleidoscope.